Nisa Investment Advisors’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.71K Sell
296
-175
-37% -$3.8K ﹤0.01% 2467
2025
Q4
$12.4K Sell
471
-175
-27% -$4.54K ﹤0.01% 2136
2025
Q3
$14.6K Hold
646
﹤0.01% 2129
2025
Q2
$12.8K Sell
646
-562
-47% -$11K ﹤0.01% 2147
2025
Q1
$20.4K Buy
1,208
+794
+192% +$13.5K ﹤0.01% 1866
2024
Q4
$7.65K Sell
414
-32
-7% -$625 ﹤0.01% 2191
2024
Q3
$9.69K Sell
446
-5
-1% -$112 ﹤0.01% 2102
2024
Q2
$8.85K Buy
451
+266
+144% +$5.55K ﹤0.01% 2184
2024
Q1
$4.01K Sell
185
-5
-3% -$124 ﹤0.01% 2141
2023
Q4
$5.49K Sell
190
-6,840
-97% -$183K ﹤0.01% 2115
2023
Q3
$188K Sell
7,030
-160
-2% -$5.46K ﹤0.01% 1321
2023
Q2
$266K Sell
7,190
-1,657
-19% -$57.8K ﹤0.01% 1259
2023
Q1
$276K Buy
8,847
+7,072
+398% +$228K ﹤0.01% 1223
2022
Q4
$53K Buy
1,775
+1,584
+829% +$56.7K ﹤0.01% 1744
2022
Q3
$8K Buy
191
+16
+9% +$802 ﹤0.01% 2228
2022
Q2
$10K Sell
175
-535
-75% -$29.4K ﹤0.01% 2187
2022
Q1
$44K Buy
+710
New +$46.7K ﹤0.01% 1875
2021
Q4
Sell
-600
Closed -$54 2271
2021
Q3
$54 Hold
600
﹤0.01% 1916
2021
Q2
$55 Buy
+600
New +$47.9K ﹤0.01% 1913

Other funds holding FLGT

Nisa Investment Advisors's FLGT Position: Q1 2026 in Review

Nisa Investment Advisors reduced its Fulgent Genetics (FLGT) stake by 37% in Q1 2026, selling an estimated $3.8K and leaving 296 shares worth $4.71K. The position accounts for ﹤0.01% of the portfolio, ranked #2467.

Nisa Investment Advisors first reported a position in FLGT in Q2 2021 and has held it in 19 quarters since. The position peaked at $276K in Q1 2023. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • Nisa Investment Advisors held 296 shares of Fulgent Genetics worth $4.71K as of Q1 2026.
  • Nisa Investment Advisors sold 175 Fulgent Genetics shares in Q1 2026, an estimated $3.8K.
  • Fulgent Genetics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2467 holding.
  • Nisa Investment Advisors first reported a position in Fulgent Genetics in Q2 2021 and has held it in 19 quarters since.
  • Nisa Investment Advisors's Fulgent Genetics position peaked at $276K in Q1 2023.
  • 157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.